[Elsevier] Toripalimab (anti-PD-1) versus High-Dose Interferon-¦Á2b as Adjuvant Therapy in Resected Mucosal Melanoma: A Phase II Randomized Trial

omnyw Post time 2022-7-19 15:40:04 | Show all posts |Read mode
Reward10points

journal£ºAnnals of Oncology

Authors£ºB. Lian; L. Si; Z. Chi; X. Sheng; Y. Kong; X. Wang; H. Tian; K. Li; L. Mao; X. Bai; B. Tang; X. Yan; S. Li; L. Zhou; J. Dai; X. Tang; F. Ran; S. Yao; J. Guo; C. Cui

Published date£º2022-7-

DOI£º10.1016/j.annonc.2022.07.002

Article link£ºhttp://dx.doi.org/10.1016/j.annonc.2022.07.002

Article Source£ºElsevier BV¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply2 Show all posts
DrRazzak Post time 2022-7-19 15:40:05 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Ramukaka Post time 2022-7-19 15:53:00 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report


Senior Member
  • post

  • reply

  • points

    560

Latest Reply



Return to the list